Metabolomic signatures of inflammation and metabolic dysregulation in relation to colorectal cancer risk.

We derived metabolomic signatures and identified individual metabolites associated with inflammation, metabolic dysregulation, and CRC, highlighting several metabolites as promising candidates involved in the inflammatory and metabolic dysregulation pathways for CRC incidence.